Paclitaxel Inhibits Synoviocyte Migration and Inflammatory Mediator Production in Rheumatoid Arthritis.
Paclitaxel Inhibits Synoviocyte Migration and Inflammatory Mediator Production in Rheumatoid Arthritis.
复制标题
紫杉醇抑制类风湿关节炎滑膜细胞迁移和炎症介质产生
DOI:
10.3389/fphar.2021.714566
复制
发表时间:
2021
影响因子:
5.6
通讯作者:
Li J
中科院分区:
文献类型:
--
作者:
Chen X;Lin H;Chen J;Wu L;Zhu J;Ye Y;Chen S;Du H;Li J
Activated fibroblast-like synoviocytes (FLSs) play a crucial role in the pathogenesis and progression of rheumatoid arthritis (RA). It is urgent to develop new drugs that can effectively inhibit the abnormal activation of RA-FLS. In our study, the RA-FLS cell line, MH7A, and mice with collagen-induced arthritis (CIA) were used to evaluate the effect of paclitaxel (PTX). Based on the results, PTX inhibited the migration of RA-FLS in a dose-dependent manner and significantly reduced the spontaneous expression of IL-6, IL-8, and RANKL mRNA and TNF-α-induced transcription of the IL-1 β, IL-8, MMP-8, and MMP-9 genes. However, PTX had no significant effect on apoptosis in RA-FLS. Mechanistic studies revealed that PTX significantly inhibited the TNF-α-induced phosphorylation of ERK1/2 and JNK in the mitogen-activated protein kinase (MAPK) pathway and suppressed the TNF-α-induced activation of AKT, p70S6K, 4EBP1, and HIF-1α in the AKT/mTOR pathway. Moreover, PTX alleviated synovitis and bone destruction in CIA mice. In conclusion, PTX inhibits the migration and inflammatory mediator production of RA-FLS by targeting the MAPK and AKT/mTOR signaling pathways, which provides an experimental basis for the potential application in the treatment of RA.
登录
查看更多内容
影响因子:
3.4
作者:
Ren X;Zhao B;Chang H;Xiao M;Wu Y;Liu Y
通讯作者:
Liu Y
影响因子:
7.3
作者:
Du, Hongyan;Zhang, Xi;Jie, Ligang
通讯作者:
Jie, Ligang
影响因子:
2.1
作者:
Xiao, Wei-Yuan;Zong, Zhen;Lao, Li-Feng
通讯作者:
Lao, Li-Feng
影响因子:
3.4
作者:
Xu J;Feng Z;Chen S;Zhu J;Wu X;Chen X;Li J
通讯作者:
Li J
影响因子:
4.9
作者:
Görtz B;Hayer S;Tuerck B;Zwerina J;Smolen JS;Schett G
通讯作者:
Schett G